Deal Announcements

Akebia Adds $2 Million Venture Capital Funding

Monday, April 25, 2011 5:36:00 AM PDT | VentureDeal Staff

   Cincinnati, Ohio  --  Pharmaceutical company Akebia Therapeutics has secured nearly $2 million in additional venture capital, according to an SEC regulatory filing.

Akebia is developing treatments for ischemia and improvement of vascular disease.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Akebia is still seeking an additional $8 million in financing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1